NCT04462783

Brief Summary

This feasibility study is being conducted to understand how discharged emergency department patients who were tested for the SARS-CoV-2 virus (COVID-19) engage with a symptom-tracking web application. Study participants that are enrolled in the study will be asked to enter daily information about their health into the CovidX web application (app.). In addition, patients will answer questions regarding anxiety levels, use a pulse oximeter to record information (if you own one or are given one). The investigators predict that participants will be able to engage with the CovidX web application over several days to weeks for the purposes of symptom tracking, and may have decreased anxiety over the study period.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 8, 2020

Completed
11 months until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2021

Completed
Last Updated

July 1, 2021

Status Verified

June 1, 2021

Enrollment Period

5 months

First QC Date

July 7, 2020

Last Update Submit

June 28, 2021

Conditions

Keywords

coronavirus

Outcome Measures

Primary Outcomes (3)

  • Change in the percent of participants using the CovidX web application (app) on 50% or greater of days

    baseline, up to 30 days

  • Average compliance rate with daily symptom tracking by day 30

    Day 30

  • Recruitment rate

    The proportion of patients approached for the study who enroll

    through study completion an average of 1 year

Secondary Outcomes (4)

  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety short form 4a

    completed at baseline (enrollment), up to 30 days

  • Change in Coronavirus Anxiety Scale

    completed at baseline (enrollment), up to 30 days

  • CovidX web application usability and utility measured adapted by mHealth App Usability Questionnaire

    30 days

  • Differences in CovidX web application engagement between patients who do and do not receive a pulse oximeter

    30 days

Study Arms (2)

Patient's symptom data without pulse oximeter

EXPERIMENTAL

Some patients may not be given a pulse oximeter to enter heart rate and O2 saturation into the CovidX application.

Other: Symptoms entered into the CovidX application

Patient's symptom data with a pulse oximeter

EXPERIMENTAL

Some patients will be given (or may have) a pulse oximeter in order to enter heart rate and O2 saturation data into the CovidX application.

Other: Symptoms entered into the CovidX application

Interventions

Participants are asked to enter symptoms into the CovidX application at least daily for 30 days. Additionally, they will enter demographic information and some survey information will be collected.

Patient's symptom data with a pulse oximeterPatient's symptom data without pulse oximeter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Reported symptoms of viral illness during ED encounter
  • Tested for SARS-CoV-2 (COVID-19) during ED encounter
  • Discharged home from the Emergency Department

You may not qualify if:

  • Prisoners
  • Residents of congregate living facilities who are already being monitored
  • Baseline oxygen requirement
  • Patients whose primary goals of care are palliative
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

COVID-19Coronavirus Infections

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Kathleen Li, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Some patients will have pulse oximeters or be given one and provide data from these.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Clinical Lecturer in Emergency Medicine

Study Record Dates

First Submitted

July 7, 2020

First Posted

July 8, 2020

Study Start

June 1, 2021

Primary Completion

November 1, 2021

Study Completion

November 1, 2021

Last Updated

July 1, 2021

Record last verified: 2021-06